Concepedia

Thomas Witthoeft

TW

4

Publications

350

Citations

4

H-Index

2001

Active since

Affiliations

University of Lübeck(Current)

Robert Bosch Hospital

Thomas Witthoeft is an author at University of Lübeck specializing in inflammation, gastroenterology, and medicine.

Top concepts

MedicineInflammationGastroenterologyImmunologyPharmacotherapyAllergySurgeryAutoimmunityImmunotherapyAutoimmune Disease

Publications per year

2001–2021

4

Publications

4

Response of Refractory Colitis to Intravenous or Oral Tacrolimus (FK506)

Klaus Fellermann, Zita Tanko, Klaus Herrlinger et al. · Inflammatory Bowel Diseases · 2002 · 161 citations · Full text

Inflammation, Mucosal Immunology, Intravenous Cyclosporine +10

Etrolizumab as induction and maintenance therapy for ulcerative colitis in patients previously treated with tumour necrosis factor inhibitors (HICKORY): a phase 3, randomised, controlled trial

Laurent Peyrin‐Biroulet, Ailsa Hart, Peter Bossuyt et al. · The Lancet. Gastroenterology & hepatology · 2021 · 89 citations · Full text

Inflammation, Anti-inflammatory, Immunology +7

Randomized, Double Blind Controlled Trial of Subcutaneous Recombinant Human Interleukin-11 Versus Prednisolone in Active Crohn's Disease

Klaus Herrlinger, Thomas Witthoeft, Andreas Raedler et al. · The American Journal of Gastroenterology · 2005 · 81 citations

Tacrolimus: a new immunosuppressant for steroid refractory inflammatory bowel disease

Klaus Fellermann, Klaus Herrlinger, Thomas Witthoeft et al. · Transplantation Proceedings · 2001 · 19 citations

Inflammation, Anti-inflammatory, Autoimmune Disease +9

Rows per page

1–4 of 4